Showing results (211-220 of 377) with videos related to
Sort By:
Pageof 38
Contemporary Clinical Trials|January 19, 2026
Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testingJinghua An, Maisha Huq, Erin Speiser, et al.Nature Medicine|September 28, 2011
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155Suhwan Chang, Rui-Hong Wang, Keiko Akagi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.Breast Cancer Research and Treatment|April 4, 2014
Long-term risk of medical conditions associated with breast cancer treatmentDeirdre A Hill, Nora K Horick, Claudine Isaacs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2014
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901Vanessa B Sheppard, Leigh Anne Faul, George Luta, et al.JMIR Cancer|March 11, 2026
Evaluation of Experiences With Ecological Momentary Assessment Among Women With Metastatic Breast Cancer: Qualitative StudyEmily P Taylor, Brenna Mossman, Mikaela A Velazquez-Sosa, et al.JCO Global Oncology|December 20, 2024
Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES StudyIlana Schlam, Kelly A Hirko, Daniela Shveid, et al.Breast Cancer Research and Treatment|January 12, 2013
Supplement use during an intergroup clinical trial for breast cancer (S0221)Gary R Zirpoli, Patrick M Brennan, Chi-Chen Hong, et al.JAMA Oncology|December 14, 2023
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical TrialBrian D Lehmann, Vandana G Abramson, E Claire Dees, et al.NPJ Breast Cancer|September 30, 2024
Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA studyIlana Schlam, D Max Smith, Cody Peer, et al.Pageof 38